COVID-19 & CancerFree One cancer patient’s struggle to get a COVID-19 test“It’s just horrifying that there isn’t a system in place” March 20, 2020Vol.46 No.12By Alexandria Carolan
COVID-19 & CancerFree Sifting through fatality data and projections on COVID-19:People with cancer, other comorbidities face highest risk March 20, 2020Vol.46 No.12By Matthew Bin Han Ong
COVID-19 & CancerFreeGuest Editorial The COVID-19 pandemic gives us the urgency—and one more chance—to address health disparities March 20, 2020Vol.46 No.12By Robert A. Winn
COVID-19 & CancerFreeGuest Editorial ASCO’s Response to COVID-19 March 18, 2020Vol.46 No.12By Richard L. Schilsky
Conversation with The Cancer LetterCOVID-19 & CancerFree Nelson: How Hopkins is managing COVID-19 pandemic March 16, 2020Vol.46 No.12By Paul Goldberg
Drugs & TargetsFree FDA grants accelerated approval to nivolumab and ipilimumab combination for hepatocellular carcinoma March 13, 2020Vol.46 No.11
Drugs & TargetsFree FDA accepts BLA for biosimilar MYL-1402O in cancer indications March 13, 2020Vol.46 No.11
Drugs & TargetsFree FDA grants Breakthrough Therapy Designation for JNJ-6372 in NSCLC indication March 13, 2020Vol.46 No.11
Drugs & TargetsFree Thermo Fisher Scientific collaborates with Janssen to co-develop companion diagnostic for cancer March 13, 2020Vol.46 No.11
